Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2025 ,inter alia, to consider and approve This is to inform the exchange ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories has informed BSE that its Board of Directors will meet on 27th November 2025 at 3:30 PM at the registered office in Bhandup West, Mumbai. The key agenda item is to consider and approve the appointment of Ms. Falguni Kumawat as the Company Secretary and Compliance Officer of the company. She will also be designated as a Key Managerial Personnel (KMP) of the company. The intimation is being made under Regulation 29(2) read with Regulation 33 of SEBI's LODR Regulations, 2015.
This is a routine compliance filing regarding a KMP appointment. The market impact is neutral as no financial or strategic decision is involved. Shareholders should note any further disclosures once the appointment is formally approved by the Board.